Search Results

There are 24409 results for: content related to: A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF)

  1. You have free access to this content
    Molecular diagnostics of myeloproliferative neoplasms

    European Journal of Haematology

    Volume 95, Issue 4, October 2015, Pages: 270–279, Stephen E. Langabeer, Hajnalka Andrikovics, Julia Asp, Beatriz Bellosillo, Serge Carillo, Karl Haslam, Lasse Kjaer, Eric Lippert, Olivier Mansier, Elisabeth Oppliger Leibundgut, Melanie J. Percy, Naomi Porret, Lars Palmqvist, Jiri Schwarz, Mary F. McMullin, Susanne Schnittger, Niels Pallisgaard, Sylvie Hermouet and on behalf of the MPN&MPNr-EuroNet

    Version of Record online : 18 MAY 2015, DOI: 10.1111/ejh.12578

  2. You have free access to this content
    Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: Proceedings from the 6th international post-ASH symposium

    American Journal of Hematology

    Volume 87, Issue 5, May 2012, Pages: 562–568, Omar Abdel-Wahab, Animesh Pardanani, Olivier A. Bernard, Guido Finazzi, John D. Crispino, Heinz Gisslinger, Robert Kralovics, Olatoyosi Odenike, Kapil Bhalla, Vikas Gupta, Giovanni Barosi, Jason Gotlib, Paola Guglielmelli, Jean-Jacques Kiladjian, Pierre Noel, Mario Cazzola, Alessandro M. Vannucchi, Ronald Hoffman, Tiziano Barbui, Juergen Thiele, Richard A. Van Etten, Tariq Mughal and Ayalew Tefferi

    Version of Record online : 28 MAR 2012, DOI: 10.1002/ajh.23169

  3. Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms

    Genes, Chromosomes and Cancer

    Volume 51, Issue 8, August 2012, Pages: 743–755, Mandy Brecqueville, Jérôme Rey, François Bertucci, Emilie Coppin, Pascal Finetti, Nadine Carbuccia, Nathalie Cervera, Véronique Gelsi-Boyer, Christine Arnoulet, Olivier Gisserot, Denis Verrot, Borhane Slama, Norbert Vey, Marie-Joelle Mozziconacci, Daniel Birnbaum and Anne Murati

    Version of Record online : 9 APR 2012, DOI: 10.1002/gcc.21960

  4. You have full text access to this Open Access content
    Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives

    Journal of Cellular and Molecular Medicine

    Volume 13, Issue 8a, August 2009, Pages: 1437–1450, Alessandro M. Vannucchi, Paola Guglielmelli, Alessandro Rambaldi, Costanza Bogani and Tiziano Barbui

    Version of Record online : 11 JUN 2009, DOI: 10.1111/j.1582-4934.2009.00827.x

  5. Myeloproliferative Neoplasms: New Translational Therapies

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 77, Issue 6, November/December 2010, Pages: 667–683, John Mascarenhas and Ronald Hoffman

    Version of Record online : 23 NOV 2010, DOI: 10.1002/msj.20225

  6. Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms and Related Conditions

    Bone Marrow Pathology, Fourth Edition

    Barbara J. Bain, David M. Clark, Bridget S. Wilkins, Pages: 239–299, 2009

    Published Online : 26 NOV 2009, DOI: 10.1002/9781444309782.ch5

  7. You have free access to this content
    Flow cytometry immunophenotypic analysis of philadelphia-negative myeloproliferative neoplasms: Correlation with histopathologic features

    Cytometry Part B: Clinical Cytometry

    Volume 88, Issue 4, July/August 2015, Pages: 236–243, Juan Ouyang, Wenli Zheng, Qi Shen, Maitrayee Goswami, Jeffrey L. Jorgensen, L. Jeffrey Medeiros and S. A. Wang

    Version of Record online : 30 DEC 2014, DOI: 10.1002/cyto.b.21215

  8. Myeloproliferative neoplasm patient symptom burden and quality of life: Evidence of significant impairment compared to controls

    American Journal of Hematology

    Volume 90, Issue 10, October 2015, Pages: 864–870, Lesley A. Anderson, Glen James, Andrew S. Duncombe, Ruben Mesa, Robyn Scherber, Amylou C. Dueck, Frank de Vocht, Mike Clarke and Mary F. McMullin

    Version of Record online : 10 SEP 2015, DOI: 10.1002/ajh.24098

  9. You have free access to this content
    Advances in Understanding and Management of Myeloproliferative Neoplasms

    CA: A Cancer Journal for Clinicians

    Volume 59, Issue 3, May/June 2009, Pages: 171–191, Alessandro M. Vannucchi, Paola Guglielmelli and Ayalew Tefferi

    Version of Record online : 16 APR 2009, DOI: 10.3322/caac.20009

  10. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression

    International Journal of Laboratory Hematology

    Volume 37, Issue 2, April 2015, Pages: 181–189, C. Hahm, H. J. Huh, Y. C. Mun, C. M. Seong, W. S. Chung and J. Huh

    Version of Record online : 21 MAY 2014, DOI: 10.1111/ijlh.12257

  11. Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasms

    Liver International

    Volume 35, Issue 8, August 2015, Pages: 2042–2049, Andrej Potthoff, Dina Attia, Sven Pischke, Ingmar Mederacke, Gernot Beutel, Kinan Rifai, Katja Deterding, Karlheinz Heiringhoff, Jürgen Klempnauer, Christian P. Strassburg, Michael P. Manns and Matthias J. Bahr

    Version of Record online : 31 MAR 2015, DOI: 10.1111/liv.12816

  12. Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis

    European Journal of Haematology

    Volume 94, Issue 2, February 2015, Pages: 152–156, Helna Pettersson, Håvar Knutsen, Erik Holmberg and Björn Andréasson

    Version of Record online : 24 JUL 2014, DOI: 10.1111/ejh.12410

  13. Myeloproliferative Neoplasms

    Postgraduate Haematology, Sixth edition

    Peter J Campbell, Anthony R Green, Pages: 686–709, 2010

    Published Online : 16 NOV 2010, DOI: 10.1002/9781444323160.ch36

  14. Inheritance of the chronic myeloproliferative neoplasms. A systematic review

    Clinical Genetics

    Volume 83, Issue 2, February 2013, Pages: 99–107, A Ranjan, E Penninga, AM Jelsig, HC Hasselbalch and OW Bjerrum

    Version of Record online : 20 NOV 2012, DOI: 10.1111/cge.12044

  15. You have free access to this content
    Guideline for investigation and management of adults and children presenting with a thrombocytosis

    British Journal of Haematology

    Volume 149, Issue 3, May 2010, Pages: 352–375, Claire N. Harrison, David Bareford, Nauman Butt, Peter Campbell, Eibhlean Conneally, Mark Drummond, Wendy Erber, Tamara Everington, Anthony R. Green, Georgina W. Hall, Beverley J. Hunt, Christopher A. Ludlam, Richard Murrin, Catherine Nelson-Piercy, Deepti H. Radia, John T. Reilly, Jon Van der Walt, Bridget Wilkins, Mary F. McMullin and British Committee for Standards in Haematology

    Version of Record online : 15 MAR 2010, DOI: 10.1111/j.1365-2141.2010.08122.x

  16. The role of mutations in epigenetic regulators in myeloid malignancies

    Immunological Reviews

    Volume 263, Issue 1, January 2015, Pages: 22–35, Brittany A. Woods and Ross L. Levine

    Version of Record online : 15 DEC 2014, DOI: 10.1111/imr.12246

  17. TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms – a multicentric study on 529 patients

    British Journal of Haematology

    Volume 174, Issue 2, July 2016, Pages: 218–226, Adrian P. Trifa, Claudia Bănescu, Mihaela Tevet, Anca Bojan, Delia Dima, Laura Urian, Tünde Török-Vistai, Viola M. Popov, Mihnea Zdrenghea, Ljubomir Petrov, Anca Vasilache, Meilin Murat, Daniela Georgescu, Mihaela Popescu, Oana Pătrinoiu, Marius Balea, Roxana Costache, Elena Coleș, Carmen Șaguna, Nicoleta Berbec, Ana-Maria Vlădăreanu, Romeo G. Mihăilă, Horia Bumbea, Andrei Cucuianu and Radu A. Popp

    Version of Record online : 7 APR 2016, DOI: 10.1111/bjh.14041

  18. Angiogenic factors are increased in circulating granulocytes and CD34+ cells of myeloproliferative neoplasms

    Molecular Carcinogenesis

    Tijana Subotički, Olivera Mitrović Ajtić, Bojana B. Beleslin-Čokić, Ronny Nienhold, Miloš Diklić, Dragoslava Djikić, Danijela Leković, Tanja Bulat, Dragana Marković, Mirjana Gotić, Constance T. Noguchi, Alan N. Schechter, Radek C. Skoda and Vladan P. Čokić

    Version of Record online : 8 JUL 2016, DOI: 10.1002/mc.22517

  19. You have free access to this content
    The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience

    American Journal of Hematology

    Volume 86, Issue 12, December 2011, Pages: 1007–1012, Luca Laurenti, Michela Tarnani, Ilaria Nichele, Stefania Ciolli, Agostino Cortelezzi, Francesco Forconi, Davide Rossi, Francesca Romana Mauro, Giovanni D'Arena, Giovanni Del Poeta, Marco Montanaro, Fortunato Morabito, Caterina Musolino, Vincenzo Callea, Lorenzo Falchi, Alessandra Tedeschi, Achille Ambrosetti, Gianluca Gaidano, Giuseppe Leone and Robin Foà

    Version of Record online : 22 SEP 2011, DOI: 10.1002/ajh.22171

  20. Dysregulation of the MIRLET7/HMGA2 axis with methylation of the CDKN2A promoter in myeloproliferative neoplasms

    British Journal of Haematology

    Volume 168, Issue 3, February 2015, Pages: 338–349, Kayo Harada-Shirado, Kazuhiko Ikeda, Kazuei Ogawa, Hiroshi Ohkawara, Hideo Kimura, Tatsuyuki Kai, Hideyoshi Noji, Soji Morishita, Norio Komatsu and Yasuchika Takeishi

    Version of Record online : 19 SEP 2014, DOI: 10.1111/bjh.13129